14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.27 $7.87 Wednesday, 24th Apr 2024 ARDX stock ended at $6.43. This is 0.626% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.31% from a day low at $6.39 to a day high of $6.66.
90 days $6.27 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
Apr 24, 2024 $6.45 $6.66 $6.39 $6.43 5 440 670
Apr 23, 2024 $6.55 $6.72 $6.38 $6.39 3 817 437
Apr 22, 2024 $6.60 $6.64 $6.38 $6.51 4 546 791
Apr 19, 2024 $6.39 $6.56 $6.27 $6.48 5 603 286
Apr 18, 2024 $6.53 $6.56 $6.39 $6.44 3 520 415
Apr 17, 2024 $6.83 $6.84 $6.53 $6.55 3 580 706
Apr 16, 2024 $6.72 $6.90 $6.65 $6.71 3 364 511
Apr 15, 2024 $7.07 $7.24 $6.75 $6.80 5 529 531
Apr 12, 2024 $7.27 $7.43 $7.01 $7.06 4 350 435
Apr 11, 2024 $7.17 $7.41 $6.99 $7.37 5 501 768
Apr 10, 2024 $6.91 $7.15 $6.85 $7.13 5 349 049
Apr 09, 2024 $7.39 $7.59 $7.12 $7.17 4 398 589
Apr 08, 2024 $7.55 $7.55 $7.15 $7.32 5 171 751
Apr 05, 2024 $7.30 $7.87 $7.14 $7.50 7 476 803
Apr 04, 2024 $7.40 $7.57 $7.13 $7.16 6 400 226
Apr 03, 2024 $7.23 $7.50 $7.13 $7.35 5 763 506
Apr 02, 2024 $7.31 $7.44 $7.10 $7.34 7 007 265
Apr 01, 2024 $7.31 $7.45 $7.11 $7.41 5 389 313
Mar 28, 2024 $7.41 $7.59 $7.25 $7.30 6 437 511
Mar 27, 2024 $7.53 $7.65 $7.31 $7.41 4 508 178
Mar 26, 2024 $7.84 $7.85 $7.40 $7.42 3 502 869
Mar 25, 2024 $7.69 $7.84 $7.65 $7.70 2 782 212
Mar 22, 2024 $7.77 $7.89 $7.63 $7.70 4 236 434
Mar 21, 2024 $7.86 $8.02 $7.73 $7.83 5 499 084
Mar 20, 2024 $7.92 $7.94 $7.55 $7.80 6 765 874
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT